 Momenta Pharmaceuticals, Inc. NASDAQ:MNTA Director Steven C. Gilman sold 13,000 shares of the stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of 32.75, for a total value of 425,750.00. Following the completion of the transaction, the director now owns 20,796 shares of the companys stock, valued at ... 